Semaglutide and beyond: a turning point in obesity pharmacotherapy
The Lancet Regional Health – Europe
Topics & Concepts
Turning pointSemaglutidePharmacotherapyObesityMedicineType 2 diabetesInternal medicineArtDiabetes mellitusEndocrinologyAestheticsPeriod (music)LiraglutideDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer